Menu Search
Equities

McKesson Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MCK:MUN

McKesson Corp

Actions
  • Price (EUR)613.20
  • Today's Change-1.60 / -0.26%
  • Shares traded5.00
  • 1 Year change+14.79%
  • Beta0.5024
Data delayed at least 15 minutes, as of Jul 18 2025 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

McKesson Corporation is a diversified healthcare services company, which focuses on advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products in the United States (U.S.). The Prescription Technology Solutions (RxTS) segment helps solve medication access, affordability and adherence challenges for patients by working across healthcare to connect patients, pharmacies, pharmacy benefit managers, health plans, and biopharma companies. The Medical-Surgical Solutions provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, hospital reference labs, and home healthcare agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Canada and Norway. It also offers oncology and specialty solutions.

  • Revenue in USD (TTM)359.05bn
  • Net income in USD3.30bn
  • Incorporated1994
  • Employees43.00k
  • Location
    McKesson Corp6555 State Highway 161IRVING 75039United StatesUSA
  • Phone+1 (972) 446-4800
  • Fax+1 (302) 636-5454
  • Websitehttps://www.mckesson.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		MCK:NYQ since
announced		Transaction
value
PRISM Vision Holdings LLCDeal completed04 Feb 202504 Feb 2025Deal completed18.34%850.00m
Community Oncology Revitalization Enterprise Ventures LLCDeal completed26 Aug 202426 Aug 2024Deal completed28.55%2.49bn
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.